- Home
- CRGY vs RCKT Comparison
CRGY vs RCKT Comparison
Compare CRGY & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRGY | RCKT |
|---|---|---|
| Founded | 1986 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 340.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CRGY | RCKT |
|---|---|---|
| Price | $8.97 | $3.44 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 14 |
| Target Price | $14.22 | ★ $29.12 |
| AVG Volume (30 Days) | ★ 4.8M | 2.3M |
| Earning Date | 11-03-2025 | 11-06-2025 |
| Dividend Yield | ★ 5.11% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.10 | N/A |
| Revenue | ★ $3,590,024,000.00 | N/A |
| Revenue This Year | $29.14 | N/A |
| Revenue Next Year | $30.46 | N/A |
| P/E Ratio | $90.51 | ★ N/A |
| Revenue Growth | ★ 32.31 | N/A |
| 52 Week Low | $6.83 | $2.19 |
| 52 Week High | $16.94 | $13.50 |
Technical Indicators
Market Signals| Indicator | CRGY | RCKT |
|---|---|---|
| Relative Strength Index (RSI) | 43.65 | 52.89 |
| Support Level | $9.35 | $3.30 |
| Resistance Level | $9.71 | $3.65 |
| Average True Range (ATR) | 0.32 | 0.19 |
| MACD | -0.06 | 0.04 |
| Stochastic Oscillator | 4.55 | 67.16 |
Price Performance
Historical ComparisonAbout CRGY Crescent Energy Company
Crescent Energy Co is an independent energy company with a portfolio of assets in key basins across the lower 48 states. The company maintains a diverse portfolio of assets in key basins across the United States, including the Eagle Ford, Rockies, Barnett, Permian, and Mid-Con. It seeks to deliver attractive risk-adjusted investment returns and predictable cash flows across cycles with a focus on operated oil and gas assets complemented by non-operated assets, mineral and royalty interests, and midstream infrastructure.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.